Stay updated with breaking news from Nuclear Countermeasures Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RedHill Biopharma Ltd (NASDAQ: RDHL) shares are down after the company announced a registered direct offering of 1.3 million American Depositary Shares, each ADS representing four hundred (400) ordinary shares, at a purchase price of $1.35 per ADS (or ADS equivalent), in a
Opaganib awarded a further $1.7 million in U.S. Government funding for development as a medical countermeasure for gastrointestinal acute radiation syndrome...
RedHill Biopharma Ltd.’s stock soared 10% premarket after the company said it has received a further $1.7 million in U.S. government funding for its partner,...
By Chris Wack RedHill Biopharma said Friday that its opaganib has been awarded a further $1.7 million in U.S. government funding, via a Small Business...
Q1/23 Talicia net revenues of $3.4 million; Cash balance of $28.8 million as of March 31, 2023[1]; Extinguishment of all debt obligations in exchange for the...